about
Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approachesEnhancing the benefits of antiretroviral therapy in Vietnam: towards ending AIDS.Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?Performance-based financing for improving HIV/AIDS service delivery: a systematic reviewEnding tuberculosis by 2030: can we do it?Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.A public health approach to hepatitis C control in low- and middle-income countries.Interventions to improve adherence to antiretroviral therapy: a rapid systematic review.Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.What's next for tuberculosis control in sub-Saharan Africa?Antiretroviral therapy in prevention of HIV and TB: update on current research effortsIntegrating antiretroviral therapy into antenatal care and maternal and child health settings: a systematic review and meta-analysis.Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission.Global policy review of antiretroviral therapy eligibility criteria for treatment and prevention of HIV and tuberculosis in adults, pregnant women, and serodiscordant couples.Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization.Programmatic Implications of Acute and Early HIV Infection.Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.Household survey of HIV incidence in Rwanda: a national observational cohort study.In vitro growth inhibitory efficacy of some target specific novel drug molecules against Theileria equi.Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.Reply to Davey et al.Methylsulfonyl benzothiazoles (MSBT) derivatives: Search for new potential antimicrobial and anticancer agents.Lessons learnt from implementation of the International Health Regulations: a systematic review.Co-trimoxazole in people on antiretroviral therapy for HIV--authors' reply.Towards national and global measurement of antiretroviral therapy effectiveness.A prospective "test-and-treat" demonstration project among people who inject drugs in Vietnam.Using strategic information for action: lessons from the HIV/AIDS response in VietnamAntimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDSThe potential impact of expanding antiretroviral therapy and combination prevention in Viet NamTowards national systems for continuous surveillance of antimicrobial resistance: Lessons from tuberculosisEvaluation of approaches to strengthen civil registration and vital statistics systems: A systematic review and synthesis of policies in 25 countries
P50
Q27021509-905EC475-3048-4853-ADFA-F0A95F620676Q27693544-24930977-249F-4AC5-9687-630133B3DB88Q28073723-268BFA19-06CF-4D7C-AEC5-4721DD26D5D6Q28359606-69628869-6DC6-4E23-95DE-FD9FD67F9898Q30061980-DA2EB518-086F-47B5-8092-88086ECD869AQ34387168-0BE452BC-2ED3-4F9F-8677-25676C5B2709Q35164735-7D992D6A-4963-4455-9A7F-AEA48B54B5F3Q35172181-D9817666-3B91-4AB7-80C0-0F4DA0A836B4Q35826952-3FC5A161-A0DF-4CE5-9566-4E619CEC47C7Q35944833-11AFB24B-702E-4F9C-BC45-7A8D9F5833FDQ36493044-2C2C15D1-2A52-4DDF-8B3F-31F2790C0883Q36509413-ACAB606E-D7C6-41E1-B6EA-DE960765B054Q36950190-3F826CA2-1EC5-49B2-A3B3-56764F9A9A4CQ37167877-4642AEFB-C034-44B4-906C-27A072763C84Q37271760-ADC18012-0FF3-4B9A-BC65-AFBF924782F2Q38063123-3989EC76-2DE4-4D05-9E9B-E19A74F19B77Q38213578-6C85B830-2A17-4E66-9466-1D524D48D1E7Q38574468-34111DE8-27B0-45B9-AC89-32E48C6ED141Q38596372-4FD260D2-2F50-4395-A9E5-121476D11C1FQ38619860-905FE397-D1D3-43EA-9BE2-34BDAA9310F2Q38628382-6D8CEA48-14EF-407F-8D46-78737B367284Q38797954-DFB2B39C-9716-461C-8330-37D2C4509891Q46143994-78CCE9EE-E3CF-4276-AEAC-DADF513E7730Q46243683-7FBF0014-5262-403F-90F4-366A05029256Q46419372-B7518FCC-890D-449B-861E-075A6EC2DD8DQ48505986-BBEAD1D9-5D83-4557-A7C4-337A6E300E3CQ50956820-D9B5F1F7-9D03-40A2-9756-8332001576D4Q51855265-23553813-3210-4C6C-9888-E716CEF65FE4Q55621886-E25631FA-016F-4F02-A30E-0223B5D42EB9Q57191160-64A82036-F59A-4AEA-AE8E-1BDA88420E14Q57280966-EFCA6B3A-317B-4C5A-8EA3-F36EB8E824BDQ57710253-703FE935-EBDB-41B6-ABFC-334B1B6C7377Q58741327-9E508292-0CEE-4BAC-9709-ECBB10BF48B4Q90329425-3142DA97-AB48-4FE2-B18C-D38F8474B2EE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9756-6593
@en
name
Amitabh B Suthar
@ast
Amitabh B Suthar
@en
Amitabh B Suthar
@nl
type
label
Amitabh B Suthar
@ast
Amitabh B Suthar
@en
Amitabh B Suthar
@nl
prefLabel
Amitabh B Suthar
@ast
Amitabh B Suthar
@en
Amitabh B Suthar
@nl
P106
P21
P31
P496
0000-0001-9756-6593